Oxehealth
Oxford
About Oxehealth
Oxehealth secures world-first medical device certification for software enabling a digital video camera to remotely detect pulse and breathing rate, with the potential to transform care for elderly and vulnerable people in rooms where staff cannot always be present. Measure pulse rate and breathing rate totally contact free, be alerted to risky activities (for example a dementia patient getting out of bed) and review objective data on activity and vital signs to inform care planning. Oxehealth gives you more time for hands on care. We are the first company in the world to certify software as a medical device which enables a secure optical sensor to measure vital signs from right across a room. Our Digital Care Assistant is paying attention to every room when you can't be there. This Software as a Service solution generates the alerts and reports clinicians, carers and custodians need, seamlessly slotted into their existing workflow. The Digital Care Assistant is helping hundreds of staff in mental health, police, prison care home, acute hospital and home care settings. A spin out from Oxford University's Department of Engineering, Oxehealth’s technology can measure pulse & breathing rate and human activity & behaviour using proprietary algorithms which harness deep learning, computer vision and signal processing techniques. We are growing fast and always on the look out for talented team mates to join us across research, engineering, operations, sales and marketing. Take a look at www.oxehealth.com - we’d love to hear from you.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $22.1M
- Funding stage: Early Stage Venture
- Last round: Non-Equity Assistance (Apr 2025)
- Website: oxehealth.com
- Phone: +44 (0) 1865 781343
Industries & Categories
Elder Care, Health Care, Home Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/oxehealth-18078 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.